Biogena Group Invest AG
Research Biogena Group Invest AG (BIO.VI) on Bullrun: market cap EUR 20.75M, P/E 74.3, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIO.VI
- ExchangeVI
- CountryAustria
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyEUR
- Market capEUR 20.75M
- P/E74.3
- Dividend yield1.0%
- Financial periodFY2026
- RevenueEUR 351.06K
- Revenue growth-4.6%
- Net incomeEUR 293.33K
Valuation Snapshot
latest market cap is EUR 20.75M; P/E is 74.3; dividend yield is 1.0%.
Peer valuation comparison
Latest P/E is 74.29x versus a Consumer Defensive sector median of 17.24x (330.9% above).
Latest dividend yield is 0.98% versus a Consumer Defensive sector median of 3.01% (67.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | EUR 351.06K | EUR 293.33K | n/a | n/a | n/a | EUR 23.62K | n/a | EUR 8.80M |
| FY2025 | EUR 368.06K | EUR 330.27K | -EUR 9.00K | n/a | 0.08 | EUR 12.28K | n/a | EUR 8.70M |
| FY2024 | EUR 166.06K | EUR 172.40K | EUR 25.00K | 99.5% | 0.04 | EUR 23.00K | n/a | EUR 8.49M |
| FY2023 | EUR 251.06K | EUR 298.19K | n/a | 99.7% | 0.07 | EUR 24.48K | n/a | EUR 8.52M |
| FY2022 | n/a | n/a | n/a | n/a | 0.18 | n/a | EUR 0 | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | EUR 20.75M | 74.3 | 1.0% | 0.05 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.05 EUR, yield 1.0%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.05 EUR |
| FY2025 | 0.05 EUR |
| FY2024 | 0.03 EUR |
| FY2023 | 0.05 EUR |
| FY2022 | 0.1 EUR |
About Biogena Group Invest AG
Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Biogena Group Invest AG's market cap?
Biogena Group Invest AG's market capitalization is EUR 20.75M.
What is Biogena Group Invest AG's P/E ratio?
Biogena Group Invest AG's price-to-earnings (P/E) ratio is 74.3.
Does Biogena Group Invest AG pay a dividend?
Biogena Group Invest AG has a dividend yield of 1.0%.
What does Biogena Group Invest AG do?
Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.